Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05467345 · ClinicalTrials.gov registry record
Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples
A clinical trial, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- 120
- Enrollment target
NCT05467345 is a clinical trial that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 120 participants.
The verdict
NCT05467345 has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to extend the intended use of two BGMSs to include testing of neonatal blood by Health Care Professionals in a clinical setting for the quantitative measurement of glucose levels in neonates.
Interventions
- DEVICE Contour Next and Contour Plus Elite BGMS testing of neonatal blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-08-24 |
| Est. Completion | 2023-03-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05467345
The ClinicalTrials.gov registry entry for NCT05467345 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contour Next and Contour Plus Elite BGMS testing of neonatal blood is the first listed.
NCT05467345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05467345 about?
NCT05467345 is a clinical study titled "Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples". The purpose of this study is to extend the intended use of two BGMSs to include testing of neonatal blood by Health Care Professionals in a clinical setting for the quantitative measurement of glucose levels in neonates.
What is the current status of trial NCT05467345?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2022-08-24. Estimated completion is 2023-03-14.
What interventions are being tested in trial NCT05467345?
The interventions under investigation include: Contour Next and Contour Plus Elite BGMS testing of neonatal blood (DEVICE).
Who is sponsoring clinical trial NCT05467345?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.